Showing 504 results

Filters Content type: News, Editors' picks, About HIV Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Treatment interruptions

My HIV is undetectable, can I stop my medication?

About HIV
July 2024
Changing treatment

Dolutegravir resistance very rare after a switch - even with detectable HIV

News
8 July 2024
Resistance

Lamivudine resistance mutation may persist for many years in some people with HIV

News
4 July 2024
Injectable & long-acting HIV treatment

Injectable HIV treatment underway in England and largely effective, but a couple of breakthrough cases raise concern

News
8 May 2024
Injectable & long-acting HIV treatment

Caution advised when prescribing long-acting injectable cabotegravir and rilpivirine to avoid drug resistance

News
30 April 2024
Sexually transmitted infections prevention

Dissent on doxyPEP: recent guidelines becoming more cautious

News
26 April 2024
Changing treatment

Changing HIV treatment

About HIV
April 2024
Resistance

Widely used HIV drug in South Africa flagged for reports of resistance – but experts say don’t panic

Editor's pick
Spotlight
16 April 2024
Resistance

Drug resistance Illustrated

About HIV
March 2024
HIV treatment

Top 5 HIV treatment stories from CROI 2024

News
18 March 2024
Sexually transmitted infections prevention

CROI 2024: DoxyPEP Video

March 2024
Resistance

CROI 2024: Dolutegravir resistance Video

March 2024
Resistance

The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?

News
12 March 2024
Resistance

New report documents increase in HIV drug resistance to dolutegravir

Editor's pick
World Health Organization
6 March 2024
Resistance

FDA Expands Indication for Biktarvy to for Resistant HIV

Editor's pick
Infectious Disease Special Edition
1 March 2024
Resistance

U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance

Editor's pick
Gilead Sciences press release
27 February 2024
How HIV works

Higher viral load during HIV infection can shape viral evolution

Editor's pick
EurekAlert!
10 January 2024
PrEP science

Resistance Mutation Associated With PrEP Use in People Newly Diagnosed With HIV in New York City

Editor's pick
TheBodyPro
5 January 2024
Resistance

History of PrEP Use Linked to M184I/V Mutation at HIV Diagnosis

Editor's pick
Infectious Disease Advisor
22 December 2023
Resistance

New HIV drugs should be classed as inferior if they carry a higher risk of resistance

News
22 December 2023
Adherence

Why taking your HIV treatment properly is important

About HIV
December 2023
Resistance

Dolutegravir resistance is rare, but some risk factors can up the odds

News
6 December 2023
Injectable & long-acting HIV treatment

Top 10 HIV Clinical Developments of 2023

Editor's pick
TheBodyPro
1 December 2023
Treatment simplification strategies

Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure

News
20 October 2023